南财智讯11月10日电，创业慧康公告，公司第一大股东葛航先生正与杭州更好智投管理咨询合伙企业 （有限合伙）筹划控制权相关事宜，可能导致公司由无实际控制人状态变更为有实际控制人状态。公司 股票自2025年11月10日开市起停牌，预计停牌时间不超过2个交易日。待相关事项确定后公司将及时发 布公告并申请复牌。本次交易事宜能否最终实施完成及实施结果尚存在不确定性，敬请广大投资者关注 后续公告并注意投资风险。 ...

证券代码：300451 证券简称：创业慧康 公告编号：2025-067 关于筹划控制权事项停牌的公告 第一大股东、持股 5%以上股东葛航先生保证公告的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、创业慧康科技股份有限公司（以下简称"公司"或"创业慧康"）第一 大股东、持股 5%以上股东葛航先生正与杭州更好智投管理咨询合伙企业（有限 合伙）筹划控制权相关事宜，该事项可能导致公司将由无实际控制人状态变更为 有实际控制人状态。经公司向深圳证券交易所申请，公司股票（股票简称：创业 慧康，股票代码：300451）自 2025 年 11 月 10 日（星期一）开市起停牌，预计 停牌时间不超过 2 个交易日。 2、本次交易事宜能否最终实施完成及实施结果尚存在不确定性。敬请广大 投资者关注后续公告并注意投资风险。 鉴于上述事项尚存在重大不确定性，为保证公平信息披露，避免造成公司股 价异常波动，维护广大投资者利益，根据《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号— ...

公告显示，创业慧康拟披露重大事项，根据深圳证券交易所《创业板股票上市规则》的有关规定，经公 司申请，公司股票(证券简称：创业慧康，证券代码：300451)于2025年11月10日开市起停牌，待公司通 过指定媒体披露相关公告后复牌，敬请投资者密切关注。 中国经济网北京11月10日讯创业慧康（300451）(300451.SZ)今日发布股票临时停牌的公告。 创业慧康发布停牌公告前的最后一个交易日，即11月7日，股价上涨，收报5.18元，涨幅7.02%。 ...

北京商报讯（记者 丁宁）11月10日早间，深交所公告，创业慧康（300451）拟披露重大事项，根据深 交所《创业板股票上市规则》的有关规定，经公司申请，公司股票于11月10日开市起停牌，待公司通过 指定媒体披露相关公告后复牌。 交易行情显示，11月7日，创业慧康收涨7.02%，收盘价为5.18元/股，全天成交金额为6.74亿元，出现明 显放量。 ...

北京商报讯（记者 丁宁）11月10日早间，深交所公告，创业慧康（300451）拟披露重大事项，根据深 交所《创业板股票上市规则》的有关规定，经公司申请，公司股票于11月10日开市起停牌，待公司通过 指定媒体披露相关公告后复牌。 针对公司相关问题，北京商报记者致电创业慧康董秘办公室，公司相关负责人表示，"不清楚停牌原 因，等中午发公告。" ...

Core Viewpoint - The company, Chuangye Huikang Technology Co., Ltd., is set to disclose significant matters, leading to a temporary suspension of its stock trading on the Shenzhen Stock Exchange starting November 10, 2025 [1] Group 1 - The company has applied for a trading suspension in accordance with the relevant regulations of the Shenzhen Stock Exchange's listing rules for the Growth Enterprise Market [1] - The stock trading will resume after the company discloses the relevant announcement through designated media [1]

Core Viewpoint - The company Chuangye Huikang Technology Co., Ltd. is set to disclose significant matters, leading to a suspension of its stock trading starting November 10, 2025, until further announcements are made through designated media [1]. Group 1 - The stock of Chuangye Huikang will be suspended from trading on November 10, 2025 [1]. - The resumption of trading will depend on the company’s disclosure of relevant announcements [1].

Group 1 - The company Chuangye Huikang Technology Co., Ltd. (stock code: 300451) is set to disclose significant matters [1] - The company's stock will be suspended from trading starting November 10, 2025, until further announcements are made through designated media [1]

Market Overview - On November 7, the AI medical sector declined by 0.83%, with Madi Technology leading the drop [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - Notable gainers included: - Chuangyi Huikang (300451) with a closing price of 5.18, up 7.02% on a trading volume of 1.3279 million shares and a turnover of 674 million yuan [1] - Other stocks showed minor fluctuations, with some experiencing slight declines: - Madi Technology (603990) closed at 16.98, down 4.12% with a trading volume of 257,500 shares and a turnover of 442 million yuan [2] Capital Flow - The AI medical sector saw a net outflow of 476 million yuan from institutional investors, while retail investors contributed a net inflow of 304 million yuan [2] - The capital flow for individual stocks indicated varied investor sentiment, with some stocks experiencing significant net inflows from retail investors despite overall sector declines [3]

Core Insights - The stock price of Chuangye Huikang increased by 2.07% on November 4, reaching 4.94 CNY per share, with a total market capitalization of 7.653 billion CNY [1] - The company has experienced a year-to-date stock price increase of 10.27%, with a recent 5-day increase of 5.33% [1] Company Overview - Chuangye Huikang Technology Co., Ltd. was established on December 10, 1997, and went public on May 14, 2015. The company is based in Hangzhou, Zhejiang Province [2] - The main business involves information technology services in the healthcare sector, including software applications, system integration, and environmental monitoring services [2] - Revenue composition includes: technical services (44.95%), software sales (44.48%), system integration (9.59%), and others (0.98%) [2] Financial Performance - For the period from January to September 2025, Chuangye Huikang reported revenue of 862 million CNY, a year-on-year decrease of 26.26%, and a net profit attributable to shareholders of -122 million CNY, a decrease of 331.69% [2] - The company has distributed a total of 230 million CNY in dividends since its A-share listing, with 30.9355 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 0.69% to 64,400, with an average of 23,711 circulating shares per person, an increase of 0.70% [2] - Notable changes in institutional holdings include a reduction in shares held by major shareholders such as Nuoan Active Return Mixed A and Southern CSI 1000 ETF [3]